Manulife US REIT is a MUST 'buy', analysts say

SINGAPORE (Nov 7): Analysts from UOB Kay Hian and RHB Research are keeping their “buy” recommendations on Manulife US REIT (MUST), with the latter calling MUST one of its top picks in the REITs sector.

This comes after MUST, the first pure-play US office REIT listed in Asia, declared a 3Q DPU of 1.51 US cents, 33.6% higher than a year ago.

Gross revenue jumped 75.3% to US$40.4 million ($55.5 million) on revenue contribution from the four Trophy and Class A quality office properties acquired in 2017 and 2018, while net property income rose 74.9% to US$25.1 million.

---

Related Stories

• DBS ups Nanofilm's FY2021 earnings estimates on indications of strong 4QFY2021
• DBS downgrades Sabana REIT to 'hold' on valuations
• Broker's Digest: Genting Singapore, Nanofilm Technologies, SGX, Kimly, Digital Core REIT

---